875 studies found for:    "Hepatitis C, Chronic"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis C, Chronic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
2 Unknown  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
3 Completed Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Irbesartan;   Drug: placebo
4 Recruiting A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Ribavirin
5 Recruiting Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
Conditions: RNA Virus Infections;   Flaviviridae Infections;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Vitamin D;   Drug: Vitamin B 12
6 Completed Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-interferon alpha 2a (drug);   Drug: Ribavirin (drug);   Drug: Interferon gamma (drug)
7 Completed Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
Conditions: HIV Infections;   Hepatitis C, Chronic;   Treatment Failure
Interventions: Drug: Peginterferon alfa2a;   Drug: Ribavirin
8 Completed
Has Results
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 18908)
9 Unknown  Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: PEG-rIL-29;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
10 Unknown  Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Conditions: Hepatitis C, Chronic;   Liver Fibrosis
Intervention: Drug: Peginterferon alpha-2b + ribavirin
11 Completed Multidisciplinary Support Program in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Other: Multidisciplinary support program
12 Completed Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention: Drug: peginterferon alfa-2a and ribavirin
13 Withdrawn Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention:
14 Completed Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
Conditions: Hepatitis C, Chronic;   Cognition Disorders;   Fatigue Syndrome, Chronic;   Major Depressive Disorder
Intervention: Drug: Interferon and ribavirin
15 Completed Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2336805;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin;   Drug: GSK2336805 Matching Placebo
16 Recruiting Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Intervention: Biological: VGX-6150
17 Completed Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced
Condition: Hepatitis C, Chronic
Intervention: Drug: BI201335
18 Active, not recruiting Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2878175;   Drug: Placebo
19 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
20 Completed Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Procedure: Liver Biopsy;   Drug: Peginterferon & amp; Ribavirin for Hepatitis C;   Drug: Pre-treatment Ribavirin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years